Clearside Biomedical bankruptcy court approves sale process; Health Ocean Limited as stalking horse

Clearside Biomedical, Inc.

Court approved bidding procedures on Dec 19, 2025; Health Ocean Limited designated as stalking horse bidder.
Monthly operating report: $3.05M cash; net loss of $490,885 for seven days ending Nov 30, 2025.
Total assets negative $24.4M, equity negative $26.9M; prepetition unsecured debt $2.3M.
No employee payroll; no professional fees paid during period; court authorized tax payments.
Sale process subject to higher or better offers; auction to follow bidding procedures.

item 1.03 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-332152
form_type: 8-K
ticker: CLSDQ
cik: 0001539029
company_name: Clearside Biomedical, Inc.
filed_at: 2025-12-29T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.687892+00:00
generated_at: 2026-05-16T12:06:12.900523+00:00
sec_items: ["1.03", "8.01", "9.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.95
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-332152
json_url: https://secwatch.observer/filing/0001193125-25-332152.json
markdown_url: https://secwatch.observer/filing/0001193125-25-332152.md
text_url: https://secwatch.observer/filing/0001193125-25-332152.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1539029/000119312525332152/0001193125-25-332152-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1539029/000119312525332152/d63805d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-332152

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.